Pacific Biosciences Of California (PACB) Non-Current Debt (2010 - 2023)
Pacific Biosciences Of California (PACB) posted quarterly Non-Current Debt of $500000.0 for Q4 2023, down 78.26% year-over-year from $2.3 million in Q4 2022, and down 99.89% quarter-over-quarter from $459.0 million in Q2 2023.
Pacific Biosciences Of California (PACB) Non-Current Debt (2010 - 2023) Analysis & Trends
Pacific Biosciences Of California's Non-Current Debt history runs 13 years deep, the most recent figure standing at $500000.0 for Q4 2023.
- In Q4 2023, Non-Current Debt fell 78.26% year-over-year to $500000.0; the TTM figure through Dec 2023 stood at $500000.0 (down 78.26% YoY), while the FY2023 annual figure was $500000.0, down 78.26% from the prior year.
- Non-Current Debt for Q4 2023 stood at $500000.0, down from $459.0 million in the prior quarter.
- The five-year high for Non-Current Debt was $459.0 million in Q2 2023, with the low at $500000.0 in Q4 2023.
- The 4-year median for Non-Current Debt is $2.3 million (2021), against an average of $96.0 million.
- The sharpest annual moves came in 2019 and 2023: Non-Current Debt gained 7.78% in 2019, then tumbled 78.26% in 2023.
- Pacific Biosciences Of California's Non-Current Debt stood at $15.8 million in 2019, then plunged by 85.44% to $2.3 million in 2021, then changed by 0.0% to $2.3 million in 2022, then sank by 78.26% to $500000.0 in 2023.
- Business Quant data shows PACB's Non-Current Debt at $500000.0 in Q4 2023, $459.0 million in Q2 2023, and $2.3 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Pacific Biosciences Of California | 394.53 Mn | 157.66 Mn | 12.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 500,000.00 |
| Jun 30, 2023 | 459.00 Mn |
| Dec 31, 2022 | 2.30 Mn |
| Dec 31, 2021 | 2.30 Mn |
| Dec 31, 2019 | 15.80 Mn |
| Dec 31, 2018 | 14.66 Mn |
| Sep 30, 2018 | 14.38 Mn |
| Jun 30, 2018 | 14.12 Mn |
| Mar 31, 2018 | 13.87 Mn |
| Dec 31, 2017 | 13.64 Mn |
| Sep 30, 2017 | 10.46 Mn |
| Jun 30, 2017 | 10.44 Mn |
| Mar 31, 2017 | 13.30 Mn |
| Dec 31, 2016 | 16.11 Mn |
| Sep 30, 2016 | 15.79 Mn |
| Jun 30, 2016 | 15.50 Mn |
| Mar 31, 2016 | 15.22 Mn |
| Dec 31, 2015 | 14.95 Mn |
| Sep 30, 2015 | 14.81 Mn |
| Jun 30, 2015 | 14.57 Mn |